glp-1 review A Comprehensive of the Role of Agonists in Weight Management and Their Effect on Metabolic Parameters Such as Blood Glucose, Cholesterol, and Blood Pressure IUPHAR review – Glucagon-like peptide-1
Description
Increased risk of type 2 diabetes in Alzheimer disease
or (ii) RCTs comparing different AOMs with active drug control
2020;8:e001706
a Values represent pooled placebo-adjusted mean differences (95% confidence interval)
This approach may benefit individuals with time constraints, though medical clearance is advisable for those with cardiovascular risk factors
The absolute risk increase is more important than the relative one for individual patients
